Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine H Smith

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
JAMA Dermatology|March 3, 2021
Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis SeverityEwan Carr, Satveer K Mahil, Anamaria Brailean, et al.
The British Journal of Dermatology|April 24, 2024
Dupilumab in chronic actinic dermatitis: a retrospective case seriesMarese O'Reilly, Alexandra Paolino, Pirunthan Pathmarajah, et al.
The British Journal of Dermatology|December 5, 2023
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
JAMA Dermatology|December 2, 2020
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators RegisterZenas Z N Yiu, Kayleigh J Mason, Philip J Hampton, et al.
The Journal of Investigative Dermatology|March 18, 2011
PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa)Andrew E Pink, Michael A Simpson, Glen W Brice, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2023
Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologicsAli Al-Janabi, Paul Martin, Adnan R Khan, et al.
The British Journal of Dermatology|April 29, 2026
Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasisHeber Rew Bright Bright, Catherine H Smith, Philip Laws, et al.
JAMA Dermatology|March 5, 2025
Effectiveness of Adalimumab Biosimilars and Originator for PsoriasisDuc Binh Phan, Anthony P Bewley, Philip Laws, et al.
The Journal of Dermatological Treatment|April 26, 2023
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort studyAngela L Bosma, Louise A A Gerbens, Hajar El Khattabi, et al.
The British Journal of Dermatology|February 6, 2023
Factors associated with depression, anxiety and severe mental illness among adults with atopic eczema or psoriasis: a systematic review and meta-analysisElizabeth I Adesanya, Julian Matthewman, Yochai Schonmann, et al.
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
JAMA Dermatology|March 3, 2021
Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis SeverityEwan Carr, Satveer K Mahil, Anamaria Brailean, et al.
The British Journal of Dermatology|April 24, 2024
Dupilumab in chronic actinic dermatitis: a retrospective case seriesMarese O'Reilly, Alexandra Paolino, Pirunthan Pathmarajah, et al.
The British Journal of Dermatology|December 5, 2023
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
JAMA Dermatology|December 2, 2020
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators RegisterZenas Z N Yiu, Kayleigh J Mason, Philip J Hampton, et al.
The Journal of Investigative Dermatology|March 18, 2011
PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa)Andrew E Pink, Michael A Simpson, Glen W Brice, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2023
Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologicsAli Al-Janabi, Paul Martin, Adnan R Khan, et al.
The British Journal of Dermatology|April 29, 2026
Serious infection risk of certolizumab compared with other systemic therapies in women with psoriasisHeber Rew Bright Bright, Catherine H Smith, Philip Laws, et al.
JAMA Dermatology|March 5, 2025
Effectiveness of Adalimumab Biosimilars and Originator for PsoriasisDuc Binh Phan, Anthony P Bewley, Philip Laws, et al.
The Journal of Dermatological Treatment|April 26, 2023
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort studyAngela L Bosma, Louise A A Gerbens, Hajar El Khattabi, et al.
The British Journal of Dermatology|February 6, 2023
Factors associated with depression, anxiety and severe mental illness among adults with atopic eczema or psoriasis: a systematic review and meta-analysisElizabeth I Adesanya, Julian Matthewman, Yochai Schonmann, et al.
Pageof 17